Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Original Article
Author Details :
Volume : 4, Issue : 4, Year : 2017
Article Page : 198-202
Abstract
2-aryl substituted benzimidazole derivatives were synthesized by using various aromatic aldehydes contains electron releasing as well as electron withdrawing groups, o-phenylenediamine and aluminium chloride as a catalyst via one-pot reaction by use of water as ecological solvent. This route provides an ecological, uncomplicated develops and give compounds in high yield. The synthesized 2-aryl substituted benzimidazole derivatives were characterized by physical (molecular weight, molecular formula, melting point, recrystallization, Rf value) and spectral data (IR and (1)H-NMR). All the synthesized compounds were evaluated for their in-vitro antibacterial activity against few gram-positive and few gram-negative microorganisms.
Keywords: o-Phenylenediamine, Aluminium chloride, Aromatic aldehydes, 2-Aryl substituted benzimidazole derivatives, Antibacterial activity
How to cite : Kumar K S, Rao A L, Rani A P, Mounika G, Ramya J S, Aluminium chloride catalyzed one-pot synthesis of 2-aryl substituted benzimidazoles and their antibacterial activity. Indian J Pharm Pharmacol 2017;4(4):198-202
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.